Report Detail
Global Immunology Drug Market Insights, Forecast to 2025
- RnM3480032 |
- 31 July, 2020 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Immunology Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Immunology Drug market is segmented into
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
Segment by Application, the Immunology Drug market is segmented into
Hospitals
Clinics
Cancer Research Centers and Institutes
Regional and Country-level Analysis
The Immunology Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunology Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunology Drug Market Share Analysis
Immunology Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunology Drug business, the date to enter into the Immunology Drug market, Immunology Drug product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
1 Study Coverage
- 1.1 Immunology Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Immunology Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Immunology Drug Market Size Growth Rate by Type
- 1.4.2 Monoclonal Antibodies (mAb)
- 1.4.3 Antibody Drug Conjugates
- 1.4.4 Interferon and Cytokine therapies
- 1.4.5 Immunosuppressive medication
- 1.5 Market by Application
- 1.5.1 Global Immunology Drug Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Cancer Research Centers and Institutes
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Immunology Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Immunology Drug Revenue 2015-2026
- 2.1.2 Global Immunology Drug Sales 2015-2026
- 2.2 Global Immunology Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Immunology Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Immunology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immunology Drug Competitor Landscape by Players
- 3.1 Immunology Drug Sales by Manufacturers
- 3.1.1 Immunology Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Immunology Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Immunology Drug Revenue by Manufacturers
- 3.2.1 Immunology Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Immunology Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Immunology Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Immunology Drug Revenue in 2019
- 3.2.5 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Immunology Drug Price by Manufacturers
- 3.4 Immunology Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Immunology Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Immunology Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Immunology Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Immunology Drug Market Size by Type (2015-2020)
- 4.1.1 Global Immunology Drug Sales by Type (2015-2020)
- 4.1.2 Global Immunology Drug Revenue by Type (2015-2020)
- 4.1.3 Immunology Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Immunology Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Immunology Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Immunology Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Immunology Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Immunology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Immunology Drug Market Size by Application (2015-2020)
- 5.1.1 Global Immunology Drug Sales by Application (2015-2020)
- 5.1.2 Global Immunology Drug Revenue by Application (2015-2020)
- 5.1.3 Immunology Drug Price by Application (2015-2020)
- 5.2 Immunology Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Immunology Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Immunology Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Immunology Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Immunology Drug by Country
- 6.1.1 North America Immunology Drug Sales by Country
- 6.1.2 North America Immunology Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Immunology Drug Market Facts & Figures by Type
- 6.3 North America Immunology Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Immunology Drug by Country
- 7.1.1 Europe Immunology Drug Sales by Country
- 7.1.2 Europe Immunology Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Immunology Drug Market Facts & Figures by Type
- 7.3 Europe Immunology Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Immunology Drug by Region
- 8.1.1 Asia Pacific Immunology Drug Sales by Region
- 8.1.2 Asia Pacific Immunology Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Immunology Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Immunology Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Immunology Drug by Country
- 9.1.1 Latin America Immunology Drug Sales by Country
- 9.1.2 Latin America Immunology Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Immunology Drug Market Facts & Figures by Type
- 9.3 Central & South America Immunology Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Immunology Drug by Country
- 10.1.1 Middle East and Africa Immunology Drug Sales by Country
- 10.1.2 Middle East and Africa Immunology Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Immunology Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Immunology Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Corporation Information
- 11.1.2 Abbott Laboratories Description and Business Overview
- 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Laboratories Immunology Drug Products Offered
- 11.1.5 Abbott Laboratories Related Developments
- 11.2 Active Biotech
- 11.2.1 Active Biotech Corporation Information
- 11.2.2 Active Biotech Description and Business Overview
- 11.2.3 Active Biotech Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Active Biotech Immunology Drug Products Offered
- 11.2.5 Active Biotech Related Developments
- 11.3 Eli Lilly and Company
- 11.3.1 Eli Lilly and Company Corporation Information
- 11.3.2 Eli Lilly and Company Description and Business Overview
- 11.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Eli Lilly and Company Immunology Drug Products Offered
- 11.3.5 Eli Lilly and Company Related Developments
- 11.4 Autoimmune Inc.
- 11.4.1 Autoimmune Inc. Corporation Information
- 11.4.2 Autoimmune Inc. Description and Business Overview
- 11.4.3 Autoimmune Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Autoimmune Inc. Immunology Drug Products Offered
- 11.4.5 Autoimmune Inc. Related Developments
- 11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Description and Business Overview
- 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Immunology Drug Products Offered
- 11.5.5 Pfizer Related Developments
- 11.6 GlaxoSmithKline plc
- 11.6.1 GlaxoSmithKline plc Corporation Information
- 11.6.2 GlaxoSmithKline plc Description and Business Overview
- 11.6.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
- 11.6.5 GlaxoSmithKline plc Related Developments
- 11.7 Seattle Genetics
- 11.7.1 Seattle Genetics Corporation Information
- 11.7.2 Seattle Genetics Description and Business Overview
- 11.7.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Seattle Genetics Immunology Drug Products Offered
- 11.7.5 Seattle Genetics Related Developments
- 11.8 Genentech
- 11.8.1 Genentech Corporation Information
- 11.8.2 Genentech Description and Business Overview
- 11.8.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Genentech Immunology Drug Products Offered
- 11.8.5 Genentech Related Developments
- 11.9 F. Hoffmann-La Roche Ltd.
- 11.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
- 11.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
- 11.9.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
- 11.9.5 F. Hoffmann-La Roche Ltd. Related Developments
- 11.10 Eisai Co.
- 11.10.1 Eisai Co. Corporation Information
- 11.10.2 Eisai Co. Description and Business Overview
- 11.10.3 Eisai Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Eisai Co. Immunology Drug Products Offered
- 11.10.5 Eisai Co. Related Developments
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Corporation Information
- 11.1.2 Abbott Laboratories Description and Business Overview
- 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Laboratories Immunology Drug Products Offered
- 11.1.5 Abbott Laboratories Related Developments
- 11.12 Sanofi Aventis LLC.
- 11.12.1 Sanofi Aventis LLC. Corporation Information
- 11.12.2 Sanofi Aventis LLC. Description and Business Overview
- 11.12.3 Sanofi Aventis LLC. Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Sanofi Aventis LLC. Products Offered
- 11.12.5 Sanofi Aventis LLC. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Immunology Drug Market Estimates and Projections by Region
- 12.1.1 Global Immunology Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Immunology Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Immunology Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Immunology Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Immunology Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Immunology Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Immunology Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Immunology Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Immunology Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Immunology Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Immunology Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Immunology Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Immunology Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Immunology Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Immunology Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Immunology Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Immunology Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Immunology Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Immunology Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Immunology Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Immunology Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Immunology Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Immunology Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Immunology Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Immunology Drug . Industry analysis & Market Report on Immunology Drug is a syndicated market report, published as Global Immunology Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Immunology Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
